Health

Congressional Insider -  Researchers at University College London and the University of Eastern Finland analyzed data from nearly 470,000 participants across four large studies. Their work, published in npj Dementia, quantified the APOE gene’s impact using population-attributable fraction methodology. This approach shows APOE e3 and e4 variants account for 72 to 93 percent of late-onset Alzheimer’s cases. Late-onset form strikes after age 65 and represents most dementia diagnoses. The study challenges prior views that e3 variant posed no risk.

FDA Announces Recall of Iced Tea, Lemonade, and Fruit Punch Sold in 5 States